TH

Timothy Haines

Chair at TenU

Greater London, England

Overview

Work Experience

  • Managing Director and Executive Partner

    2023 - Current

  • Managing Partner: Abingworth became part of Carlyle (NASDAQ: CG) on 1 August 2022.

    2022 - 2023

  • Chairman and Managing Partner

    2019 - 2022

  • Managing Partner

    2015 - 2019

  • Partner

    2005 - 2015

  • Chair

    2024

  • Non Executive Chair

    2024

  • Advisory Board Member

    2022

  • CEO

    2000 - 2005

    Acquired by Otsuka Pharmaceuticals

  • CEO Intervascular Inc. and Patient Monitoring

    1993 - 2000

  • General Manager / VP R and D and Manufacturing

    1990 - 1993

  • CEO

    1987 - 1990

    Acquired by Depuy (J and J) 1990

  • General Manager

    1983 - 1987

Relevant Websites